Health
NIH Director Faces Senate Scrutiny on Budget and Outbreaks
Senators grilled the NIH director over budget concerns, leadership issues, and viral outbreaks. The session highlighted ongoing challenges in funding and public health.
Coverage timeline — 2 articles
STAT News
A type of targeted chemotherapy developed by China-based Kelun-Biotech and licensed to Merck cut the risk of tumor progression by 65% in patients with lung cancer, according to Phase 3…
2026-05-21 21:00 UTC
STAT News
Besides showing skepticism on the budget, senators grilled the NIH director about a leadership vacuum, two viral outbreaks, and the pace of funding.
2026-05-21 21:06 UTC